Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Technical Analysis
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by wallop13on Jul 14, 2016 11:14am
179 Views
Post# 25052225

RE:Technical Analysis

RE:Technical AnalysisWhy did the second guy refuse to comment on the stock?

retiredcf wrote: Second stock in the clip. GLTA

https://www.bnn.ca/video/keith-richards-and-craig-aucoin-part-two~910644

2016-07-13 WATCH Keith Richards
 
It fell out of bed in the later part of 2015.  There is one piece of encouraging news.  It is bouncing off a low point right now.  The peaks are getting lower while the trough is remaining relatively flat.  Watch for it to break out.
 
Login to show your approval   Login to show your disapproval / Be the first to comment
Price:
$26.650
Subject:
TECHNICAL AND FUNDAMENTAL ANALYSIS
Bias:
CAUTIOUS
Owned:
Unknown


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities